Panama vs Paraguay: Access to anti-retroviral drugs, female
Panama
55.0%
in 2024
Paraguay
55.0%
in 2024
Panama rank
111th
Paraguay rank
111th
Access to anti-retroviral drugs, female over time
- Panama
- Paraguay
How they compare
Panama currently reports 55.0% against 55.0% in Paraguay, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Panama ahead.
Panama ranks 111th and Paraguay ranks 111th of 141 countries.
Across the 3 decades both report, Panama averaged higher in 2 and Paraguay in 1.
Head to head by decade
| Decade | Panama | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.9% | 6.1% | 10.8% | Panama |
| 2010s | 40.8% | 37.9% | 2.9% | Panama |
| 2020s | 50.0% | 52.4% | 2.4% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Panama or Paraguay?
- Panama, at 55.0% against 55.0% in Paraguay as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Panama and Paraguay?
- 0.0%, with Panama ahead.
- How many years of comparable data are there for Panama and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do Panama and Paraguay rank globally for access to anti-retroviral drugs, female?
- Panama ranks 111th and Paraguay ranks 111th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.